115 related articles for article (PubMed ID: 6530765)
41. The prospects of immunosuppression in type I diabetes.
Bach JF; Feutren G; Boitard C
Adv Nephrol Necker Hosp; 1988; 17():321-40. PubMed ID: 3124546
[No Abstract] [Full Text] [Related]
42. Effect of FUT-175, a new synthetic protease inhibitor, on the development of lupus nephritis in (NZB x NZW) F1 mice.
Ikehara S; Shimamura K; Aoyama T; Fujii S; Hamashima Y
Immunology; 1985 Aug; 55(4):595-600. PubMed ID: 4018844
[TBL] [Abstract][Full Text] [Related]
43. [Cyclosporin in dermatoses, especially in severe therapy-resistant psoriasis].
van Joost T; Heule F; Stolz E
Ned Tijdschr Geneeskd; 1986 Apr; 130(17):762-5. PubMed ID: 3713885
[No Abstract] [Full Text] [Related]
44. [Therapy of systemic lupus erythematosus--studies using disease models. 1. The effect of MHC on lupus nephritis in (NZB x NZW)F1--a therapeutic suggestion].
Sato H; Hirose S; Shirai S
Nihon Rinsho; 1984 Dec; 42(12):2791-5. PubMed ID: 6530763
[No Abstract] [Full Text] [Related]
45. Systemic lupus erythematosus.
Goust JM; Tsokos G
Immunol Ser; 1993; 58():437-49. PubMed ID: 8424987
[No Abstract] [Full Text] [Related]
46. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH
Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
[TBL] [Abstract][Full Text] [Related]
47. [Cyclosporin in experimental and clinical medicine].
Zaputović L; Rukavina D
Lijec Vjesn; 1986 Apr; 108(4):150-5. PubMed ID: 3713427
[No Abstract] [Full Text] [Related]
48. [Autoimmune diseases and immunological abnormalities seen in New Zealand mice and SLE in man].
Shirai S; Koika T
Ryumachi; 1977 Oct; 17(5):516-25. PubMed ID: 304250
[No Abstract] [Full Text] [Related]
49. [Cyclosporin A].
Alijotas Reig J; Ordi Ros J; Viradell Tarrés M
Med Clin (Barc); 1985 Mar; 84(11):462-3. PubMed ID: 3990414
[No Abstract] [Full Text] [Related]
50. [Cyclosporin A in the therapy of hematologic diseases].
Raghavachar A; Frickhofen N; Heimpel H
Dtsch Med Wochenschr; 1987 Apr; 112(14):556-9. PubMed ID: 3829939
[No Abstract] [Full Text] [Related]
51. [Structural and functional changes in liver microsomes of NZB mice in the course of an autoimmune disease].
Kaznacheev VP; Gromova OA; Kozlov VA; Tsyrlov IB; Liakhovich VV
Biull Eksp Biol Med; 1973 Dec; 76(12):55-9. PubMed ID: 4781675
[No Abstract] [Full Text] [Related]
52. [Letter: Antinuclear autoimmunization in Swan mice. Prevention and regression by treatment with thymosin].
Monier JC; Deschaux P; Fontanges R
Nouv Presse Med; 1975 Feb; 4(7):507. PubMed ID: 1079341
[No Abstract] [Full Text] [Related]
53. [Use of cyclosporin A in autoimmune diseases].
Schädelin J; Von Graffenried B
Presse Med; 1987 Mar; 16(11):542-3. PubMed ID: 2951703
[No Abstract] [Full Text] [Related]
54. Cyclosporin and autoimmune disease.
Bach JF
Lancet; 1991 Jul; 338(8758):59-60. PubMed ID: 1676116
[No Abstract] [Full Text] [Related]
55. [Cyclosporin A--a new immunosuppressant].
Robak T
Pol Arch Med Wewn; 1984 Feb; 71(2):127-34. PubMed ID: 6377252
[No Abstract] [Full Text] [Related]
56. Combined steroid-cyclosporin treatment of chronic autoimmune diseases. Clinical results and assessment of nephrotoxicity by renal biopsy.
Miescher PA; Favre H; Chatelanat F; Mihatsch MJ
Klin Wochenschr; 1987 Aug; 65(15):727-36. PubMed ID: 3626435
[TBL] [Abstract][Full Text] [Related]
57. [Cyclosporin and autoimmune diseases. 1: Experimental bases].
Feutren G; Bach JF
Rev Med Interne; 1987; 8(1):91-8. PubMed ID: 3550987
[TBL] [Abstract][Full Text] [Related]
58. Cyclosporin: use outside transplantation.
Thomson AW; Neild GH
BMJ; 1991 Jan; 302(6767):4-5. PubMed ID: 1991188
[No Abstract] [Full Text] [Related]
59. [Cyclosporin: a selective immunosuppressor in hepatology].
Mentha G; Houssin D
Gastroenterol Clin Biol; 1986 Oct; 10(10):641-7. PubMed ID: 3539688
[No Abstract] [Full Text] [Related]
60. Cyclosporin for diabetes?
Lancet; 1986 Jul; 2(8499):140. PubMed ID: 2873403
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
